Literature DB >> 26614908

G-protein inhibition profile of the reported Gq/11 inhibitor UBO-QIC.

Jyrki P Kukkonen1.   

Abstract

UBO-QIC (FR900359) is the only currently available Gq/11 protein inhibitor. However, its characterization has not been published, and we thus set out to do this. Gi, Gs and Gq protein-mediated responses were assessed utilizing endogenous or heterologously expressed receptors in Chinese hamster ovary cells. UBO-QIC, at 1 μM, was an effective inhibitor of the Gq-mediated responses, but was inactive at Gi- and Gs-mediated responses. Gq/11 and G16 responses were additionally compared in HEL92.1.7 cells, showing inhibition of Gq/11 responses. However, UBO-QIC also appeared to inhibit G16. Further studies are required to establish its profile with respect to the different Gq-family proteins.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenylyl cyclase; G(i); G(q); G(s); Heterotrimeric G-protein; Phospholipase C

Mesh:

Substances:

Year:  2015        PMID: 26614908     DOI: 10.1016/j.bbrc.2015.11.078

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Gaq proteins: molecular pharmacology and therapeutic potential.

Authors:  Danielle Kamato; Partha Mitra; Felicity Davis; Narin Osman; Rebecca Chaplin; Peter J Cabot; Rizwana Afroz; Walter Thomas; Wenhua Zheng; Harveen Kaur; Margaret Brimble; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2016-11-04       Impact factor: 9.261

Review 2.  Heterotrimeric Gq proteins as therapeutic targets?

Authors:  Evi Kostenis; Eva Marie Pfeil; Suvi Annala
Journal:  J Biol Chem       Date:  2020-03-02       Impact factor: 5.157

3.  Orexin receptors in GtoPdb v.2021.3.

Authors:  Paul Coleman; Luis de Lecea; Anthony Gotter; Jim Hagan; Daniel Hoyer; Thomas Kilduff; Jyrki P Kukkonen; Rod Porter; John Renger; Jerome M Siegel; Gregor Sutcliffe; Neil Upton; Christopher J Winrow
Journal:  IUPHAR BPS Guide Pharm CITE       Date:  2021-09-02

4.  On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2016-03-05       Impact factor: 5.858

5.  A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin-biased signaling.

Authors:  Caroline M Gorvin; Valerie N Babinsky; Tomas Malinauskas; Peter H Nissen; Anders J Schou; Aylin C Hanyaloglu; Christian Siebold; E Yvonne Jones; Fadil M Hannan; Rajesh V Thakker
Journal:  Sci Signal       Date:  2018-02-20       Impact factor: 8.192

6.  Functional evidence for biased inhibition of G protein signaling by YM-254890 in human coronary artery endothelial cells.

Authors:  Qianman Peng; Saud Alqahtani; Mohammed Zahid A Nasrullah; Jianzhong Shen
Journal:  Eur J Pharmacol       Date:  2020-11-03       Impact factor: 4.432

7.  Cell-permeable high-affinity tracers for Gq proteins provide structural insights, reveal distinct binding kinetics and identify small molecule inhibitors.

Authors:  Markus Kuschak; Vigneshwaran Namasivayam; Muhammad Rafehi; Jan H Voss; Jaspal Garg; Jonathan G Schlegel; Aliaa Abdelrahman; Stefan Kehraus; Raphael Reher; Jim Küppers; Katharina Sylvester; Sonja Hinz; Michaela Matthey; Daniela Wenzel; Bernd K Fleischmann; Alexander Pfeifer; Asuka Inoue; Michael Gütschow; Gabriele M König; Christa E Müller
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.